Literature DB >> 3516685

Measurement of bactericidal activity in body fluids as a clinical research procedure.

P Dejace, J Klastersky.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3516685     DOI： 10.1007/bf02013470

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  26 in total

1.  The "tough case" of bacterial endocarditis.

Authors:  E JAWETZ
Journal:  Circulation       Date:  1959-09       Impact factor: 29.690

2.  Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin.

Authors:  E L Middleman; A Watanabe; H Kaizer; G P Bodey
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

3.  Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia.

Authors:  J P Sculier; J Klastersky
Journal:  Am J Med       Date:  1984-03       Impact factor: 4.965

4.  Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.

Authors:  S C Schimpff; H Gaya; J Klastersky; M H Tattersall; S H Zinner
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

5.  Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphylococcus aureus.

Authors:  H Lagast; J Klastersky; H Standiford; A Viollier
Journal:  Infection       Date:  1984 May-Jun       Impact factor: 3.553

6.  Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa.

Authors:  Y Van Laethem; M Husson; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

7.  The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.

Authors:  W McNamee; G L Drusano; B A Tatem; H C Standiford
Journal:  J Antimicrob Chemother       Date:  1984-11       Impact factor: 5.790

8.  Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.

Authors:  Y Van Laethem; H Lagast; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

9.  Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.

Authors:  D J Winston; R C Barnes; W G Ho; L S Young; R E Champlin; R P Gale
Journal:  Am J Med       Date:  1984-09       Impact factor: 4.965

10.  Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.

Authors:  H W Jaffe; A L Schroeter; G H Reynolds; A A Zaidi; J E Martin; J D Thayer
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191
View more
  1 in total

1.  Bactericidal activity and killing rate of serum in volunteers receiving ciprofloxacin alone or in combination with vancomycin.

Authors:  P Van der Auwera; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.